Bolt Biotherapeutics

BOLTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.782 M

$4.05 +4.65%

Close of 7 Aug 2026

Revenue

$7.70M

#3220 by revenue

Earnings

-$33.4M

Loss-making

Shares outstanding

1,921,567

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#445Moleculin BiotechMBRX$7.98M
#446CNS PharmaceuticalsCNSP$7.86M
#447Bolt BiotherapeuticsBOLT$7.78M
#448MetaViaMTVA$7.69M
#449BiovieBIVI$7.54M

Where these numbers come from

Share counts and financials for Bolt Biotherapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.